Skip to main content
Livermore
Livermore
ZHEN

Apellis Pharmaceuticals, Inc.

APLSDelisted May 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001492422

Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Apellis Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of APLS: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders3024263−35
Shares113.1M99.4K115.4M+2.41M (+2.1%)
Value$6.65B$5.84M$4.43B−$2.21B (−33.3%)

4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to APLS in Q2 2024
InstitutionSharesValue% of portfolio
Voloridge Investment Management, LLC689,108$26.4M0.10%
Braidwell LP611,800$23.5M0.74%
Capital Fund Management S.A.201,487$7.73M0.09%
Trexquant Investment LP149,160$5.72M0.09%
Rock Springs Capital Management LP140,700$5.40M0.16%
Man Group plc77,229$2.96M0.01%
Simplex Trading, LLC70,072$2.69M0.09%
HAP Trading, LLC64,997$2.49M1.09%
Squarepoint Ops LLC61,258$2.35M0.01%
Y-Intercept (Hong Kong) Ltd60,522$2.32M0.13%
Twinbeech Capital LP58,072$2.23M0.04%
Exome Asset Management LLC46,900$1.80M1.60%
J. Safra Sarasin Holding AG37,543$1.44M0.03%
Group One Trading, L.P.34,699$1.33M0.04%
LMR Partners LLP33,900$1.30M0.03%
Schonfeld Strategic Advisors LLC31,566$1.21M0.01%
Two Sigma Investments, LP27,546$1.06M0.00%
Panagora Asset Management Inc23,640$906.8K0.00%
Fox Run Management, L.L.C.22,102$847.8K0.16%
Teachers Retirement System of the State of Kentucky18,912$725.0K0.01%
STRS Ohio17,650$677.1K0.00%
Savant Capital, LLC13,598$521.6K0.01%
Corton Capital Inc.13,556$520.0K0.27%
Prelude Capital Management, LLC12,934$496.1K0.04%
Mirae Asset Global ETFs Holdings Ltd.9,198$381.9K0.00%
Corebridge Financial, Inc.2,077$79.7K0.00%
Ronald Blue Trust, Inc.448$26.3K0.00%
Clearstead Advisors, LLC425$16.3K0.00%
Ashton Thomas Private Wealth, LLC282$10.8K0.00%
Coppell Advisory Solutions LLC79$3.03K0.00%
Innealta Capital, LLC56$2.15K0.00%
MV Capital Management, Inc.2$770.00%

Sold out (67)

Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of APLS in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Frazier Life Sciences Management, L.P.885,165$52.0M
Iron Triangle Partners LP550,000$32.3M
Driehaus Capital Management LLC503,039$29.6M
Cormorant Asset Management, LP400,000$23.5M
Altitude Crest Partners Inc.287,277$16.9M
Point72 Asset Management, L.P.267,823$15.7M
Amundi248,483$11.8M
Marshall Wace, LLP171,873$10.1M
Affinity Asset Advisors, LLC165,000$9.70M
Redmile Group, LLC155,000$9.11M
Integral Health Asset Management, LLC150,000$8.82M
Senator Investment Group LP140,000$8.23M
Saturn V Capital Management LLC71,463$4.20M
HRT Financial LP68,575$4.03M
Lord, Abbett & Co. LLC54,000$3.17M
Axiom Investors LLC50,770$2.98M
Campbell & CO Investment Adviser LLC38,024$2.24M
Cubist Systematic Strategies, LLC36,994$2.17M
Ikarian Capital, LLC35,092$2.06M
Polar Asset Management Partners Inc.32,200$1.89M
Boothbay Fund Management, LLC24,825$1.46M
Jacobs Levy Equity Management, Inc20,057$1.18M
Danske Bank A/S11,180$657.2K
Level Four Advisory Services, LLC10,694$640.1K
Neuberger Berman Group LLC10,675$627.5K
Brevan Howard Capital Management LP10,415$612.2K
Harvest Management LLC10,300$605.4K
Wynnefield Capital Inc10,000$587.8K
Legato Capital Management LLC9,825$577.5K
Soros Fund Management LLCSuperinvestorSoros Fund Management8,948$526.0K
PEAK6 Investments LLC8,562$503.3K
Qube Research & Technologies Ltd8,481$498.5K
Emerald Advisers, LLC7,751$455.6K
Worth Venture Partners, LLC7,700$452.6K
Axq Capital, LP6,900$405.6K
Creative Planning6,867$403.6K
Moody Aldrich Partners LLC6,431$378.0K
Aigen Investment Management, LP5,560$326.8K
XTX Topco Ltd5,440$319.8K
Readystate Asset Management LP5,438$319.6K
LPL Financial LLC5,227$307.2K
JustInvest LLC5,075$298.3K
Commonwealth Equity Services, LLC4,919$289.0K
Summit Trail Advisors, LLC4,465$262.5K
Pearl River Capital, LLC4,259$250.3K
Ethic Inc.4,103$241.2K
Prime Capital Investment Advisors, LLC4,004$235.4K
Integrated Wealth Concepts LLC3,867$227.1K
Gotham Asset Management, LLC3,513$206.5K
Oppenheimer & Co Inc3,500$205.7K
Woodward Diversified Capital, LLC3,500$205.7K
Altfest L J & Co Inc3,414$201.0K
Knights of Columbus Asset Advisors LLC3,172$186.4K
Quarry LP3,000$176.3K
Aquatic Capital Management LLC2,300$135.2K
American International Group, Inc.1,685$99.0K
BI Asset Management Fondsmaeglerselskab A/S1,510$89.0K
Quantbot Technologies LP1,480$87.0K
Natixis1,339$78.7K
Emerald Mutual Fund Advisers Trust1,020$60.0K
Future Financial Wealth Managment LLC500$29.4K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC401$23.6K
New Covenant Trust Company, N.A.55$3.23K
TD Private Client Wealth LLC21$1.23K
Geneos Wealth Management Inc.18$1.06K
Fortitude Family Office, LLC6$353
Quest Partners LLC1$59

Not filed for Q2 2024 yet (4)

Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APLS in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG80,642$4.74M
Cambridge Trust Co11,500$676.0K
Cipher Capital LP4,568$268.5K
Handelsinvest Investeringsforvaltning2,697$159.0K